Health Condition 1: C710- Malignant neoplasm of cerebrum, except lobes and ventricles
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 18-60 years GCS more than 13
Exclusion criteria
Exclusion criteria: Electrolyte imbalance(hypernatremia) Patients with severe cardiac, respiratory, or renal disease Patients with known absolute or relative contraindications for placement of the TEE probe or surgical positioning (prone position or requirement of extreme neck flexion, oesophageal strictures) will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare brain relaxation score between equiosmolar doses of Mannitol (20%) and mannitol (10%) plus glycerol (10%) combination in patients undergoing elective supratentorial tumor surgeries.Timepoint: 20 minutes after administration of study drug | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the ? TEE derived parameters [LV end diastolic area (EDA), end systolic area (ESA), fractional area change (FAC), stroke volume (SV), left ventricular outflow tract velocity time integral (LVOT-VTI) and cardiac output (CO) ] ? Serum osmolarity ? Subdural ICP ? Serum sodium,urea,creatinine,urine output ? Hemodynamic parameters (HR,BP)Timepoint: baseline (after induction of anaesthesia), initiation of study drug, completion of study drug infusion, and then 30 minutes for next 2 hours followed by hourly recordings till the end of the procedure. Blood gas analysis, random blood glucose(RBS), and Serum osmolarity will be performed prior to- and two hours after administration of study drug | — |
Countries
India
Contacts
jipmer